Work

Addition of Rituximab Abrogates Ibrutinib-Induced Lymphocytosis and Promotes More Rapid Decrease in Absolute Lymphocyte Counts in Patients with Relapsed Chronic Lymphocytic Leukemia

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.1998.1998

Authors: Ekaterina Kim, Lillian Werner, Michael J Keating, William G. Wierda, Alessandra Ferrajoli, Zeev Estrov, Gracy Zacharian, Thomas J. Kipps, Hagop M. Kantarjian, Donna Neuberg, Susan O'Brien, Jan A. Burger

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, University of California San Diego

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979447390

FWCI: 0.151

Cites:

Cited by: 1

Related to: 10